机构地区:[1]Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,People’s Republic of China [2]Institute of Mechanics,Chinese Academy of Sciences,Beijing 100190,People’s Republic of China [3]Institute of Electrical Engineering,Chinese Academy of Sciences,Beijing 100190,People’s Republic of China [4]CAS Key Laboratory of Regenerative Biology,Joint School of Life Sciences,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,People’s Republic of China,Guangzhou Medical University,Guangzhou 511436,People’s Republic of China [5]Biological Sciences,University of Southampton,University Road,Southampton SO171BJ,UK [6]School of Light Industry and Engineering,South China University of Technology,Guangzhou 510641,People’s Republic of China [7]University of Electronic Science and Technology of China,Chengdu 611731,People’s Republic of China
出 处:《Research》2024年第4期442-457,共16页研究(英文)
基 金:funded by the Key Project for Instrument Development Program-Ministry of Finance[Grant No.ZDYZ2012-3];Operational Support Project of Instrument Development-Chinese Academy of Sciences[Grant No.1187000169];Project of Automated Stem Cell Induction and Culture Instrument Development-Chinese Academy of Sciences[Grant No.1187000170];Scientific Instrument Development Program-Chinese Academy of Sciences[Grant Nos.ZDKYYQ20210006 and YJKYYQ20210042];Key Research Program of Chinese Academy of Sciences[Grant No.O2222001];Guangdong Basic and Applied Basic Research Foundation[Grant No.2022A1515110435];Guangzhou Basic and Applied Basic Research Project[Grant No.2023A04J0107];Project funded by China Postdoctoral Science Foundation[Grant No.2021M693192];Guangdong International Scientific Research Cooperation Project[Grant No.2022A0505050037];Science and Technology Planning Project of Guangdong Province[Grant No.2023B1212060050].
摘 要:Somatic cell reprogramming generates induced pluripotent stem cells(iPSCs),which serve as a crucial source of seed cells for personalized disease modeling and treatment in regenerative medicine.However,the process of reprogramming often causes substantial lineage manipulations,thereby increasing cellular heterogeneity.As a consequence,the process of harvesting monoclonal iPSCs is labor-intensive and leads to decreased reproducibility.Here,we report the first in-house developed robotic platform that uses a pin-tip-based micro-structure to manipulate radial shear flow for automated monoclonal iPSC colony selection(~1 s)in a non-invasive and label-free manner,which includes tasks for somatic cell reprogramming culturing,medium changes;time-lapse-based high-content imaging;and iPSCs monoclonal colony detection,selection,and expansion.Throughput-wise,this automated robotic system can perform approximately 24 somatic cell reprogramming tasks within 50 days in parallel via a scheduling program.Moreover,thanks to a dual flow-based iPSC selection process,the purity of iPSCs was enhanced,while simultaneously eliminating the need for single-cell subcloning.These iPSCs generated via the dual processing robotic approach demonstrated a purity 3.7 times greater than that of the conventional manual methods.In addition,the automatically produced human iPSCs exhibited typical pluripotent transcriptional profiles,differentiation potential,and karyotypes.In conclusion,this robotic method could offer a promising solution for the automated isolation or purification of lineage-specific cells derived from iPSCs,thereby accelerating the development of personalized medicines.
关 键 词:PROGRAMMING thereby PURITY
分 类 号:R32[医药卫生—人体解剖和组织胚胎学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...